Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Change in Inventory (2023 - 2025)

Historic Change in Inventory for Fennec Pharmaceuticals (FENC) over the last 3 years, with Q3 2025 value amounting to $276000.0.

  • Fennec Pharmaceuticals' Change in Inventory rose 15498.01% to $276000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 129646.02%. This contributed to the annual value of -$579000.0 for FY2024, which is 13664.56% down from last year.
  • As of Q3 2025, Fennec Pharmaceuticals' Change in Inventory stood at $276000.0, which was up 15498.01% from $797000.0 recorded in Q2 2025.
  • Fennec Pharmaceuticals' 5-year Change in Inventory high stood at $797000.0 for Q2 2025, and its period low was -$502000.0 during Q3 2024.
  • In the last 3 years, Fennec Pharmaceuticals' Change in Inventory had a median value of $316000.0 in 2023 and averaged $219818.2.
  • As far as peak fluctuations go, Fennec Pharmaceuticals' Change in Inventory plummeted by 25886.08% in 2024, and later soared by 89625.0% in 2025.
  • Fennec Pharmaceuticals' Change in Inventory (Quarter) stood at $401000.0 in 2023, then plummeted by 116.21% to -$65000.0 in 2024, then skyrocketed by 524.62% to $276000.0 in 2025.
  • Its Change in Inventory stands at $276000.0 for Q3 2025, versus $797000.0 for Q2 2025 and $344000.0 for Q1 2025.